Literature DB >> 5835976

The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

T L Sato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5835976

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  16 in total

1.  Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.

Authors:  J L Cuche; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

2.  Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.

Authors:  M J Turnbull; B R Ballinger
Journal:  Psychopharmacologia       Date:  1973-05-21

3.  Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.

Authors:  D G Jones; J A Lenman; M A Robertson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

4.  Urinary homovanillic acid in phaeochromocytoma.

Authors:  T L Sato; A Sjoerdsma
Journal:  Br Med J       Date:  1965-12-18

5.  Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.

Authors:  S E Gitlow; L B Dziedzic; S W Dziedzic
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

6.  Urinary catecholamine metabolites (vanylmandelic and homovanillic acids) in the rat after subchronic treatment with sodium nitrate or nitrite.

Authors:  S Laurens; P Fritsch; G de Saint Blanquat
Journal:  Experientia       Date:  1982-04-15

7.  Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients.

Authors:  R E Rangno; J S Kaufmann; J H Cavanaugh; D Island; J T Watson; J Oates
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

8.  Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.

Authors:  J L Cuche; O Kuchel; A Barbeau; J Genest
Journal:  Can Med Assoc J       Date:  1975-02-22       Impact factor: 8.262

9.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

10.  Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.

Authors:  F S Messiha; T H Hsu; J R Bianchine
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.